Skip to main content
Clinical Trials/NCT04735133
NCT04735133
Completed
Not Applicable

The Effect of Surgical Wound Complications Profilactic Negative Pressure Wound Therapy in Patients With High Risk Colorectal Cancer Surgery

TC Erciyes University1 site in 1 country50 target enrollmentNovember 18, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
TC Erciyes University
Enrollment
50
Locations
1
Primary Endpoint
surgical wound complications (SWC)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study was conducted as a randomized controlled trial in order to determine the effect of prophylactic negative pressure wound therapy for the prevention of surgical site complications in high-risk colorectal cancer surgery.

Hypothesis: Prophylactic negative pressure wound therapy applied after open colorectal cancer surgery to high-risk patients affects surgical wound complications.

pNBYT group: The study was completed with a total of 50 patients, 24 of intervention group anda 26 of the control group, who met the inclusion criteria at the surgical oncology service of a university hospital.

The data were collected using Patient Identification Form, Surgical Procedure Form, Wound Follow-up Chart and ASEPSİS Wound Scoring System. Ethics committee approval and written informed consent of the individuals was taken in the research.

The data were analyzed in SPSS Statistics 24.0 program using Shapiro Wilk test and Q-Q graphs, Independent Sample t test, Mann Whitney U test, Chi-square, Cochran's Q and Friedman test. The value of p<0.05 was accepted for the statistical significance level. It was determined that the groups were similar in terms of identification and surgical procedure characteristics.

Detailed Description

The effects of negative pressure wound treatment applied to high-risk patients after open colorectal cancer surgery on four SWCs, including surgical site infections, hematoma, seroma, and wound dehiscence, were studied. The study started before surgery and lasted up to one month after surgery. Preoperatively, patients fasted for eight hours before the operation and were required to take a shower with 2% chlorhexidine gluconate at night. The patients who required surgical hair removal were shaved with a clipper in the operating room before the operation. Also, patients received 1g of ampicillin + sulbactam/cefazolin within 60 minutes before the incision.

Registry
clinicaltrials.gov
Start Date
November 18, 2018
End Date
February 15, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hatice Yüceler Kaçmaz

Research Sssistant (PhD)

TC Erciyes University

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing open colorectal cancer surgery, clean-contaminated (Class-II) or contaminated (Class-III) wounds, ASA 2, 3, or 4, and fulfilling at least one of the following criteria were included:
  • 75 years old and above,
  • Chronic disease such as Diabetes (DM), Chronic obstructive pulmonary disease (COPD), Heart failure (Ejection fraction ≤ 40%), Preoperative anemia (Hb≤10mg/dl),
  • Nutritional problems (BMI 30 kg / m2 and over, malnutrition (NRS 2002 score 3 and over or albumin≤3 mg/dl),
  • Regular steroids or anticoagulants,
  • Neoadjuvant chemotherapy and radiotherapy.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

surgical wound complications (SWC)

Time Frame: postoperative 30th day

surgical site infection, seroma, hematoma, wound dehiscence/evisceration

Secondary Outcomes

  • The ASEPSIS Wound Scoring System(All participants will be followed up 4 times during a month (seven days, 15th, 21st, and 30th days)
  • length of stay in the hospital(30days)

Study Sites (1)

Loading locations...

Similar Trials